Es Pacli 30 Injection
Marketer
Esperer Bioresearch Pvt Ltd
Salt Composition
Paclitaxel (30mg)
Overview Es Pacli 30 Injection
Pacli-30 Injection is a chemotherapy agent indicated for treating breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's prescription; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include nausea, vomiting, and fatigue. Serious side effects such as edema (hand and lip swelling), alopecia (hair loss), and weight increase are possible. Your doctor might prescribe additional medication to mitigate these. Report any unexplained bleeding or bruising, sore throat, mouth sores, or fever immediately. This medication can decrease blood cell counts, increasing infection risk. Regular blood tests monitoring blood cell levels and liver function are necessary. Inform your physician of any pre-existing heart, liver, or kidney conditions, or the use of any other medications, especially anti-infectives, before starting treatment. Interactions with other drugs are possible; disclose all medications. This medication is contraindicated during pregnancy and breastfeeding. Consistent use of effective contraception by both partners is crucial throughout treatment to prevent pregnancy.
Primary Ingredients of Es Pacli 30 Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Es Pacli 30 Injection
Cancers of the breast, lung (non-small cell type), and pancreas.
Major Benefits of Es Pacli 30 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Es Pacli 30 Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Es Pacli 30 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Es Pacli 30 Injection works:
Pacli 30 Injection is a cancer treatment that disrupts the microtubules essential for cancer cell division and proliferation. This action inhibits tumor growth and ultimately leads to cancer cell death.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Es Pacli 30 Injection is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Administering Es Pacli 30 Injection during gestation carries established risks to the fetus. Its use should be avoided except in extreme circumstances where a physician deems the potential benefits outweigh the known hazards to the mother's life. Physician consultation is mandatory.
Breast feedingUNSAFE
Breastfeeding mothers should not use Es Pacli 30 Injection. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Es Pacli 30 Injection can induce adverse reactions that might impair driving ability. While driving between treatment cycles isn't inherently prohibited, the medication's alcohol content suggests caution regarding driving.
KidneySAFE IF PRESCRIBED
Es Pacli 30 Injection poses no known safety risk for individuals with kidney conditions; no dosage modification is advised. Nevertheless, consultation with a physician is recommended if you have pre-existing kidney disease.
LiverCAUTION
Patients with liver impairment should use Es Pacli 30 Injection cautiously, potentially requiring dose modification. Severe liver disease contraindicates the use of Es Pacli 30 Injection; physician consultation is advised.
What if you forget to take Es Pacli 30 Injection :
NA
Facts to Know About Es Pacli 30 Injection
| Label | Value |
|---|---|
| Chemical Category | Taxane-based drugs |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Taxanes: Antimicrotubule Agents |
3,018 People bought this recently